3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
13
Burkitt Lymphoma
7
Lung Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Carcinoma, Non-Small-Cell Lung
4
Sarcoma, Ewing
3
Recurrence
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Hodgkin Disease
3
Teratoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
HIV Infections
2
Ganglioneuroblastoma
2
Central Nervous System Neoplasms
2
Carcinoma, Embryonal
2
Wilms Tumor
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Etoposide
×
30 days
×
Clear all
No trials found.